No significant difference in HR or LV mass or volume before and after treatment was detected between the groups, with only the end-diastolic volume showing a decreasing trend in the LAV-treated group (Fig. 1 D-F and Supplementary Table 2 reporting the mean values and standard deviations).
← all excerpts
Healthy longevity-associated protein improves cardiac function in murine models of cardiomyopathy with preserved ejection fraction.
1
—
—